Fischer Medical Ventures Limited Completes Conversion of Warrants into Equity Shares
Fischer Medical Ventures Limited has finalized the allotment and conversion of a significant number of convertible warrants into equity shares following its Board meeting on August 11, 2026. The move involves converting 23 lakh warrants into common stock at an issue price of Rs. 23.40 per share.The company approved the allotment of 23,00,000 Equity Shares with a face value of Re. 1/- each. The shares were issued at an issue price of Rs. 23.40, generating a premium of Rs. 22.40 per share.
This transaction was executed in cash, receiving the remaining exercise price equivalent to 75% of the warrant exercise price. This partial payment aspect means that the company received Rs. 17.55 per warrant. The total consideration received from this conversion stands at Rs. 4,03,65,000/- (Four Crores Three Lakhs Sixty Five Thousand Only).
The details pertaining to the allottee and the warrants converted are as follows:
| Name of the Allottee | Category | No. of Warrants Converted into Equity Shares | Total Consideration Received (75%) |
|---|---|---|---|
| Mr. Shankar Varadharajan | Promoter | 23,00,000 | Rs. 4,03,65,000 |
This conversion strengthens the company's capitalization structure following the exercise of options available to the Share Warrant Holder (a promoter category person).
FISCHER Stock Price Movement
Today, shares of Fischer Medical Ventures Limited shed value, closing down 0.97% at ₹38.47 after trading for the session. The stock recorded a volume of 287,685 during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.